Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates positive financial performance with strong adjusted EBITDA growth, improved operating margins, and increased AI revenue. The shareholder return plan is robust with significant share repurchases and dividends. The partnership with Virtusa is expected to enhance productivity and margins. Despite some uncertainties in the Learning segment and vague responses in the Q&A, the overall sentiment is positive, supported by AI growth and shareholder returns. Given the market cap, a positive stock price movement of 2% to 8% is expected over the next two weeks.
Revenue Revenue performance was impacted by unfavorable comparables in Research and soft market conditions in Learning. Research Publishing revenue was up 4% excluding AI revenue. Total revenue was up 1% on a reported basis and flat at constant currency.
AI Revenue Generated $42 million in AI revenue year-to-date, above last year's total of $40 million. $7 million of AI revenue was realized in Q3. Expected to deliver AI revenue of $45 million to $50 million this year, up from $40 million in fiscal '25 and $23 million in fiscal '24. Growth attributed to strategic projects and partnerships.
Adjusted EBITDA Adjusted EBITDA was up 12% in Q3, with a 250 basis point improvement in margin. Year-to-date, adjusted EBITDA was up 6% in Research and down 8% in Learning. Corporate expenses on an adjusted EBITDA basis were down 21% for the quarter and 12% year-to-date.
Operating Cash Flow Operating cash flow nearly doubled to $103 million in Q3. Year-to-date, operating cash flow was up $51 million.
Adjusted Operating Margin Adjusted operating margin improved by 280 basis points in Q3.
Shareholder Returns Repurchases doubled in Q3 to $70 million year-to-date as part of a $100 million full-year target. Returned $126 million in dividends and repurchases in 9 months, a 37% increase over the prior year.
Research Publishing Revenue up 4% at constant currency and adjusted EBITDA up 6%. Submissions and output up 26% and 11%, respectively. Growth driven by global R&D spend, AI productivity, and expansion in Open Access journals.
Learning Segment Revenue was down 2% in Q3, with a 5% decline in Professional offsetting 1% growth in Academic. Year-to-date, Learning revenue was down 7% with adjusted EBITDA down 8%. Segment EBITDA margin declined 50 basis points to 34.8%.
AI Gateway Platform: Launched a platform embedding peer-reviewed content into platforms like Claude and AWS, with 9,000 researchers registered in 4 months.
Advanced Journal Brand: Expanded portfolio with 8 new journals planned and 50% revenue growth in Advanced Science.
Clinical Outcome Assessments (COA): Expanded COA instruments from 800,000 in 2021 to nearly 7 million today, partnering with IQVIA for pharmaceutical trials.
Global Expansion in Research: Research submissions and output grew 26% and 11%, respectively, with strong demand across all regions.
China and India Growth: China saw growth in submissions and corporate sales, while India submissions increased by 43% year-to-date.
Cost Savings: Corporate expenses on an adjusted EBITDA basis down 21% for the quarter and 12% year-to-date.
Tech Transformation: Announced a 5-year managed services partnership with Virtusa to modernize enterprise technology and reduce costs.
AI Revenue Growth: Generated $42 million in AI revenue year-to-date, surpassing last year's total of $40 million.
Partnership Ecosystem: Secured partnerships with IQVIA, OpenEvidence, and others to embed content into AI workflows and clinical decision-making.
Stock price amid AI fears: The company acknowledges concerns about its stock price due to AI fears in the market, but expresses confidence in its position in the AI economy.
Revenue performance: Revenue was impacted by unfavorable comparables in Research and soft market conditions in Learning.
Learning segment challenges: The Learning segment faced macroeconomic and channel headwinds, including corporate and consumer spending headwinds and Amazon inventory management adjustments.
Research Solutions decline: Research Solutions experienced a 3% decline due to lower corporate spending on recruiting and lower database revenue.
Proposed U.S. funding cuts: The company navigated around proposed U.S. funding cuts to science and education, which could have impacted research funding.
AI revenue dependency: The company’s AI revenue growth is significant, but there is a dependency on maintaining and expanding partnerships and customer base.
Macroeconomic and channel conditions: Learning segment continues to face challenges from macroeconomic and channel conditions, impacting revenue and growth.
Copyright lawsuits: There are approximately 70 copyright lawsuits involving AI in the U.S., which could have implications for the company.
Operational transformation risks: The company is undergoing a technology transformation, including a managed services partnership with Virtusa, which carries risks related to execution and cost savings realization.
Revenue Growth: Revenue growth is expected to be in the low single digits for fiscal '26, with Research expected to finish at the top end of the market.
Adjusted EBITDA Margin: Adjusted EBITDA margin is now expected to finish at the high end of the 25.5% to 26.5% range, up from 24% last year.
Adjusted EPS: Adjusted EPS is expected to be at the high end of the $3.90 to $4.35 range, up from $3.64 last year.
Free Cash Flow: Free cash flow is reaffirmed at approximately $200 million, driven by EBITDA growth, lower interest payments, and favorable working capital.
AI Revenue: AI revenue is expected to reach $45 million to $50 million in fiscal '26, up from $40 million in fiscal '25 and $23 million in fiscal '24. Another big year for AI revenue is anticipated in fiscal '27.
Research Publishing Growth: Research Publishing is expected to grow at the high end of the market's long-term rate, driven by robust publishing output, steady growth in renewals, market share gains, and society wins.
Learning Segment: Learning is expected to improve to a steady state in fiscal '27, focusing on franchise authors, digital growth, and inclusive access.
Operational Excellence: Meaningful margin expansion is expected in fiscal '27 from tech transformation, corporate expense reduction, and AI productivity gains.
Copyright Settlements: Copyright court decisions, including the Anthropic copyright settlement, are expected to materialize in fiscal '27, with the share of the settlement known by summer.
Dividend and Repurchases: We've returned $126 million in dividend and repurchases in just 9 months, a 37% increase over prior year.
Dividend Yield: Our current dividend yield is approximately 4.5%, supported by a healthy payout ratio.
Share Repurchases: Repurchases doubling in Q3 to $70 million year-to-date as part of a $100 million full year target.
Share Repurchase Target: Target of $30 million for Q4, putting us around 3 million shares repurchased for the year.
The earnings call summary indicates positive financial performance with strong adjusted EBITDA growth, improved operating margins, and increased AI revenue. The shareholder return plan is robust with significant share repurchases and dividends. The partnership with Virtusa is expected to enhance productivity and margins. Despite some uncertainties in the Learning segment and vague responses in the Q&A, the overall sentiment is positive, supported by AI growth and shareholder returns. Given the market cap, a positive stock price movement of 2% to 8% is expected over the next two weeks.
Despite strong research publishing revenue and improved margins, negative factors such as declining learning and professional segment revenues, economic uncertainty, and AI revenue volatility counterbalance the positives. Increased share repurchases and dividends offer some support, but the overall sentiment remains neutral. Given the market cap, the stock is likely to see minimal movement over the next two weeks.
The earnings call presents mixed signals: revenue declined slightly, but research solutions revenue grew significantly. The partnership with Anthropic could enhance future growth, but its financial impact remains unclear. The Q&A indicates management's optimism, yet lacks detailed strategies for addressing specific declines. Strong fundamentals and improved financial metrics, like the debt ratio, offset some concerns. Market reaction is likely to remain neutral, with a market cap of $2.19 billion suggesting moderate volatility.
The earnings call highlights strong financial performance with a 31% increase in EPS and improved margins. Despite some risks like competitive pressures and regulatory issues, the company's strategic initiatives, including AI licensing and increased shareholder returns, are promising. The Q&A section revealed management's optimism about AI monetization and shareholder returns, although some responses were vague. The market cap suggests moderate volatility, and the overall sentiment is positive, expecting a stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.